BioDelivery Sciences International   Report issue

For profit Phase 2 Phase 3
Founded: Raleigh NC United States (1997)
Status: Acquired by Collegium Pharmaceutical, Inc. (2022)

Organization Overview

First Clinical Trial
2006
NCT00293020
First Marketed Drug
2009
fentanyl (Innovar)
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

BDSI | BioDelivary Sciences Internantional, Inc. | BioDelivery Sciences International